JPMORGAN CHASE & CO - SONNET BIOTHERAPEUTC HLDNG I ownership

Back to all holdings Add to watchlist

SONNET BIOTHERAPEUTC HLDNG I's ticker is and the CUSIP is 83548R105. A total of 25 filers reported holding SONNET BIOTHERAPEUTC HLDNG I in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
EDGAR links
Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of SONNET BIOTHERAPEUTC HLDNG I
ValueSharesWeighting
Q1 2022$5,000–14,088
+469500.0%
0.00%–
Q3 2020$0–30.0%0.00%–
Q2 2020$0–3–0.00%–
 Download
Other shareholders
SONNET BIOTHERAPEUTC HLDNG I shareholders Q1 2022
NameSharesValueWeighting ↓
IFP Advisors, Inc 2,000$13,0000.00%
View complete list of SONNET BIOTHERAPEUTC HLDNG I shareholders